NASDAQ:OPK OPKO Health (OPK) Stock Price, News & Analysis $1.37 -0.02 (-1.44%) Closing price 04:00 PM EasternExtended Trading$1.37 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About OPKO Health Stock (NASDAQ:OPK) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OPKO Health alerts:Sign Up Key Stats Today's Range$1.34▼$1.4050-Day Range$1.31▼$1.7352-Week Range$0.98▼$1.75Volume2.47 million shsAverage Volume2.34 million shsMarket Capitalization$1.02 billionP/E RatioN/ADividend YieldN/APrice Target$1.55Consensus RatingHold Company Overview OPKO Health, Inc. is a healthcare company focused on diagnostics and pharmaceuticals. Through its diagnostics businesses, the company provides laboratory services and specialized tests intended to support the detection, diagnosis and management of disease. Its operations include BioReference Health, a clinical laboratory business serving physicians, hospitals, employers and patients, as well as the 4Kscore test, which helps assess the risk of aggressive prostate cancer. OPKO’s pharmaceutical business develops and commercializes treatments for conditions including kidney disease, endocrine disorders and growth-related conditions. Its products include Rayaldee, an extended-release formulation of calcifediol used to treat secondary hyperparathyroidism in adults with chronic kidney disease and vitamin D insufficiency. The company has also been involved in the development and commercialization of growth hormone therapies, including somatrogon, which is marketed in certain regions through a collaboration with Pfizer. Headquartered in Miami, Florida, OPKO serves customers and patients in the United States and internationally through its laboratory, diagnostic and pharmaceutical activities. The company expanded its laboratory presence through the acquisition of Bio-Reference Laboratories in 2015. OPKO is led by Phillip Frost, who serves as executive chairman and chief executive officer.AI Generated. May Contain Errors. Read More OPKO Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreOPK MarketRank™: OPKO Health scored higher than 34% of companies evaluated by MarketBeat, and ranked 742nd out of 884 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.8 / 5Analyst RatingHold Consensus RatingOPKO Health has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 strong buy rating, 1 buy rating, 3 hold ratings, and 1 sell rating.Upside PotentialOPKO Health has a consensus price target of $1.55, representing about 13.1% upside from its current price of $1.37.Amount of Analyst CoverageOPKO Health has only been the subject of 3 research reports in the past 90 days.Read more about OPKO Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for OPKO Health are expected to decrease in the coming year, from ($0.23) to ($0.28) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OPKO Health is -15.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of OPKO Health is -15.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOPKO Health has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about OPKO Health's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.72% of the float of OPKO Health has been sold short.Short Interest Ratio / Days to CoverOPKO Health has a short interest ratio ("days to cover") of 10.55, which indicates bearish sentiment.Change versus previous monthShort interest in OPKO Health has recently increased by 4.14%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOPKO Health does not currently pay a dividend.Dividend GrowthOPKO Health does not have a long track record of dividend growth. News and Social Media3.6 / 5News Sentiment0.82 News SentimentOPKO Health has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 12 news articles for OPKO Health this week, compared to 4 articles on an average week.Search InterestOnly 6 people have searched for OPK on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.MarketBeat Follows4 people have added OPKO Health to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, OPKO Health insiders have not sold or bought any company stock.Percentage Held by Insiders44.72% of the stock of OPKO Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions64.63% of the stock of OPKO Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about OPKO Health's insider trading history. Receive OPK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OPKO Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OPK Stock News HeadlinesHere's Why You Should Retain WAT Stock in Your Portfolio for NowOctober 8 at 3:13 PM | finance.yahoo.com10x Genomics & Fred Hutch Join Forces on Cancer Biomarker ResearchOctober 8 at 3:13 PM | finance.yahoo.comCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.October 8 at 1:00 AM | Paradigm Press (Ad)Bruker Gains 66.3% in a Year: What's Driving the Rally?October 8 at 3:13 PM | finance.yahoo.comReasons to Add Globus Medical Stock to Your Portfolio NowOctober 7 at 1:42 PM | finance.yahoo.comBDX Expands U.S. Manufacturing With $19B Healthcare InvestmentOctober 7 at 1:42 PM | finance.yahoo.comGE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE DealOctober 6 at 2:53 PM | finance.yahoo.comHere's Why You Should Add Merit Medical Stock to Your Portfolio NowOctober 6 at 2:53 PM | finance.yahoo.comSee More Headlines OPK Stock Analysis - Frequently Asked Questions How have OPK shares performed this year? OPKO Health's stock was trading at $1.26 at the beginning of the year. Since then, OPK stock has increased by 8.7% and is now trading at $1.37. How were OPKO Health's earnings last quarter? OPKO Health, Inc. (NASDAQ:OPK) posted its earnings results on Monday, July, 27th. The biotechnology company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.07. The business's revenue was up 4.3% compared to the same quarter last year. Read the conference call transcript. How do I buy shares of OPKO Health? Shares of OPK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of OPKO Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that OPKO Health investors own include Humana (HUM), Voyager Therapeutics (VYGR), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH) and AUO (AUOTY). Company Calendar Last Earnings7/27/2026Today10/08/2026Next Earnings (Estimated)11/04/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 OPK's financial health is in the Green zone, according to TradeSmith. OPK has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:OPK CIK944809 Webwww.opko.com Phone(305) 575-4100Fax305-575-6015Employees1,373Year Founded2007Price Target and Rating Average Price Target for OPKO Health$1.55 High Price Target$1.60 Low Price Target$1.50 Potential Upside/Downside+13.1%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage6 Analysts Profitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$225.68 million Net Margins-12.40% Pretax Margin-13.58% Return on Equity-5.88% Return on Assets-3.83% Debt Debt-to-Equity Ratio0.28 Current Ratio3.35 Quick Ratio2.93 Sales & Book Value Annual Sales$606.90 million Price / Sales1.68 Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book0.82Miscellaneous Outstanding Shares746,330,000Free Float412,570,000Market Cap$1.02 billion OptionableOptionable Beta1.51 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:OPK) was last updated on 10/8/2026 by MarketBeat.com Staff. From Our PartnersThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredThe Man Who Called Trump’s 2016 Win says, “Beware November 3rd”In 2016, one election model gave Hillary Clinton a 99% chance to win. Jim Rickards went on air and called it f...Paradigm Press | SponsoredChina ATTACK on American Dollar set for 11/12/2026A former Wall Street Journal personal finance expert warns China may be setting the stage for a major move aga...International Living | SponsoredYou ignored me once and it cost you... big time.In 2022, Karim Rahemtulla called Rolls-Royce the best value play in market history. Shares have since climbed ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
